Answers are grounded in this paper and cite their sources.
Electrochemical sensors play a pivotal role in advancing therapeutic drug monitoring (TDM) and personalized therapy.However, the insufficient s electivity o f e lectrochemical s ensors b ased o n C ytochromes P 450 p oses a great need for innovative machine learning (ML) integrated with cyclic voltammograms (CV) obtained from electrochemical sensors and cyclic voltammetry to construct a fully-automated system for accomplishing the precise identification and quantification o f m ultiple d rugs i n t he p atients' b lood.A n e ffective M L-based m ethod i s p roposed i n t his p aper with the adaptive transformation of Gaussian Mixture Model (GMM) algorithm for Gaussian feature extraction from the redox peak with peculiar characterisation and a novel Artificial Neural Network (ANN)-based model IdentQuantNet for the drug identification and quantification.The simulated dataset and measured dataset of Cyclophosphamide (CP) and Ifosfamide (IFO), proposed here as model drugs, are demonstrated to validate the efficacy of our proposed method.Our method can achieve the precision at 100 % for identification task and the Mean Absolute Error (MAE) at 4.88 and 6.67 for CP and IFO for the quantification task on the measured dataset.
No takes yet. Share an insight, caveat, or question.
Du et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: